Veru Shares Pop on Novo Wegovy Tie-Up, Uncertainty Lingers Over Key Clause
Veru Inc. shares stayed active premarket Friday as the biotech said it has a supply deal with Novo Nordisk tied to a weight-loss study using Wegovy. Benzinga data had the stock at $3.70 before the open at 7:01 a.m. ET. The move followed Thursday’s rally, when it closed at $4.23, up 88% for the day.
